MDxHealth (MDXH) Enterprise Value (2021 - 2026)
MDxHealth (MDXH) has disclosed Enterprise Value for 6 consecutive years, with -$29.0 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 38.03% to -$29.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$29.0 million through Dec 2025, up 38.03% year-over-year, with the annual reading at -$29.0 million for FY2025, 38.03% up from the prior year.
- Enterprise Value hit -$29.0 million in Q4 2025 for MDxHealth, up from -$46.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $22.5 million in Q4 2022 to a low of -$48.2 million in Q4 2021.
- Historically, Enterprise Value has averaged -$17.0 million across 5 years, with a median of -$29.0 million in 2025.
- Biggest five-year swings in Enterprise Value: crashed 1218.65% in 2021 and later soared 146.66% in 2022.
- Year by year, Enterprise Value stood at -$48.2 million in 2021, then soared by 146.66% to $22.5 million in 2022, then dropped by 25.51% to $16.8 million in 2023, then tumbled by 379.19% to -$46.8 million in 2024, then surged by 38.03% to -$29.0 million in 2025.
- Business Quant data shows Enterprise Value for MDXH at -$29.0 million in Q4 2025, -$46.8 million in Q4 2024, and $16.8 million in Q4 2023.